The ATN system categorizes biomarkers into three groups: Aβ (A), tau pathology (T), and neurodegeneration or neuronal injury (N), which collectively represent the key pathological processes underlying AD [5]. The gene discussed is MAPT; the disease is Alzheimer disease.